These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8645654)
1. The impact of maternal age on the cost effectiveness of Down's syndrome screening. Torgerson DJ Br J Obstet Gynaecol; 1996 Jun; 103(6):581-3. PubMed ID: 8645654 [No Abstract] [Full Text] [Related]
2. The impact of maternal age on the cost effectiveness of Down's syndrome screening. Dunstan FD; Nix AB Br J Obstet Gynaecol; 1997 Feb; 104(2):269-70. PubMed ID: 9070155 [No Abstract] [Full Text] [Related]
4. Marginal costs and benefits. Torgerson DJ; Spencer A BMJ; 1996 Jan; 312(7022):35-6. PubMed ID: 8555859 [TBL] [Abstract][Full Text] [Related]
5. [Cost-benefit analysis of prenatal screening for trisomy 21 through analysis of HCG in maternal blood]. Seror V; Moatti JP; Muller F; Le Galès C; Boué A Rev Epidemiol Sante Publique; 1993; 41(1):3-15. PubMed ID: 8465062 [TBL] [Abstract][Full Text] [Related]
6. An economic appraisal of screening for Down's syndrome in pregnancy using maternal age and serum alpha fetoprotein concentration. Gill M; Murday V; Slack J Soc Sci Med; 1987; 24(9):725-31. PubMed ID: 2440113 [TBL] [Abstract][Full Text] [Related]
7. [Cost effectiveness analysis of prenatal screening of trisomy 21 by maternal serum markers (hCG)]. Seror V; Moatti JP; Muller F; Le Gales C; Boue A J Gynecol Obstet Biol Reprod (Paris); 1992; 21(8):915-22. PubMed ID: 1491137 [TBL] [Abstract][Full Text] [Related]
8. An economic appraisal of alternative pre-natal screening programmes for Down's syndrome. Shackley P; McGuire A; Boyd PA; Dennis J; Fitchett M; Kay J; Roche M; Wood P J Public Health Med; 1993 Jun; 15(2):175-84. PubMed ID: 7688977 [TBL] [Abstract][Full Text] [Related]
9. [Cost-benefit analysis of the prevention of Down's syndrome by means of prenatal diagnosis during early pregnancy]. Flatz VG Fortschr Med; 1978 Jun; 96(24):1255-6, 1295. PubMed ID: 149085 [No Abstract] [Full Text] [Related]
10. The impact of maternal age on the cost effectiveness of Down's syndrome screening. Macintosh MC Br J Obstet Gynaecol; 1996 Nov; 103(11):1175-7. PubMed ID: 8917017 [No Abstract] [Full Text] [Related]
11. The value of screening for Down's syndrome in a socioeconomically deprived area with a high ethnic population. Ford C; Moore AJ; Jordan PA; Bartlett WA; Wyldes MP; Jones AF; MacKenzie WE Br J Obstet Gynaecol; 1998 Aug; 105(8):855-9. PubMed ID: 9746377 [TBL] [Abstract][Full Text] [Related]
12. Pre-natal screening for Down's syndrome. Phillips A; Wakeman A J Public Health Med; 1994 Mar; 16(1):114-5; author reply 116-7. PubMed ID: 8080557 [No Abstract] [Full Text] [Related]
13. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869 [TBL] [Abstract][Full Text] [Related]
14. Antenatal screening for Down's syndrome. Wald NJ; Kennard A; Hackshaw A; McGuire A Health Technol Assess; 1998; 2(1):i-iv, 1-112. PubMed ID: 9561893 [No Abstract] [Full Text] [Related]
16. Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. Gilbert RE; Augood C; Gupta R; Ades AE; Logan S; Sculpher M; van Der Meulen JH BMJ; 2001 Aug; 323(7310):423-5. PubMed ID: 11520837 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness and accuracy of prenatal Down syndrome screening strategies: should the combined test continue to be widely used? Gekas J; Durand A; Bujold E; Vallée M; Forest JC; Rousseau F; Reinharz D Am J Obstet Gynecol; 2011 Feb; 204(2):175.e1-8. PubMed ID: 21074138 [TBL] [Abstract][Full Text] [Related]
19. Screening programme for prevention of Down's syndrome. Stein Z; Susser M; Guterman AV Lancet; 1973 Feb; 1(7798):305-10. PubMed ID: 4119182 [No Abstract] [Full Text] [Related]